Suppr超能文献

接受和未接受环孢素A治疗的肾移植患者的肾小球和肾小管功能

Glomerular and tubular function in renal transplant patients treated with and without ciclosporin A.

作者信息

Hansen J M, Fogh-Andersen N, Leyssac P P, Strandgaard S

机构信息

Department of Clinical Physiology and Nuclear Medicine, Division of Renal and Cardiovascular Physiology, Univeristy of Copenhagen, Denmark.

出版信息

Nephron. 1998 Dec;80(4):450-7. doi: 10.1159/000045219.

Abstract

The present study evaluated whether chronically administered low-dose (<5 mg/kg) ciclosporin A (CsA) affects renal haemodynamics and tubular function in renal transplant recipients (RTx) when studied at nadir CsA blood levels. The renal clearance of lithium was used as an index of proximal tubular outflow of sodium and water. Effective renal plasma flow, glomerular filtration rate, and renal clearance of lithium were studied in 67 stable non-diabetic RTx and 44 healthy controls. Forty-eight of the RTx were treated with CsA, prednisone, and azathioprine. Nineteen were treated exclusively with prednisone and azathioprine. In RTx with a good graft function (serum-creatinine <125 micromol/l), no specific CsA-induced renal haemodynamic and tubular dysfunctions were evident. In CsA-treated RTx with a slightly reduced renal function (serum creatinine 125-180 micromol/l) a decrease in fractional proximal tubular reabsorption was found. The renal clearances of urate and magnesium were comparable between RTx treated with or without CsA, and a significant correlation between glomerular filtration rate and renal clearance of urate was found. CsA-treated RTx had a significantly higher blood pressure, independent of glomerular filtration rate and segmental tubular function. In conclusion, at nadir CsA blood levels, no specific CsA-induced tubular dysfunction evaluated by the renal lithium clearance method could be demonstrated in RTx receiving chronically low-dose CsA. The hyperuricaemia commonly seen in RTx seems to be mainly caused by the reduced glomerular filtration rate.

摘要

本研究评估了长期给予低剂量(<5 mg/kg)环孢素A(CsA)在CsA血药浓度最低点时,对肾移植受者(RTx)的肾血流动力学和肾小管功能的影响。锂的肾清除率被用作近端肾小管钠和水流出的指标。在67例病情稳定的非糖尿病肾移植受者和44例健康对照者中,研究了有效肾血浆流量、肾小球滤过率和锂的肾清除率。48例肾移植受者接受了CsA、泼尼松和硫唑嘌呤治疗。19例仅接受泼尼松和硫唑嘌呤治疗。在移植肾功能良好(血清肌酐<125 μmol/l)的肾移植受者中,未发现CsA特异性诱导的肾血流动力学和肾小管功能障碍。在肾功能略有下降(血清肌酐125 - 180 μmol/l)的接受CsA治疗的肾移植受者中,发现近端肾小管重吸收率降低。接受或未接受CsA治疗的肾移植受者之间尿酸和镁的肾清除率相当,且发现肾小球滤过率与尿酸肾清除率之间存在显著相关性。接受CsA治疗的肾移植受者血压显著更高,且与肾小球滤过率和节段性肾小管功能无关。总之,在CsA血药浓度最低点时,采用肾锂清除率方法评估,在长期接受低剂量CsA的肾移植受者中未发现CsA特异性诱导的肾小管功能障碍。肾移植受者中常见高尿酸血症似乎主要由肾小球滤过率降低引起。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验